Lisi, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 5.368
EU - Europa 4.020
AS - Asia 2.472
SA - Sud America 542
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 54
OC - Oceania 8
Totale 12.636
Nazione #
US - Stati Uniti d'America 5.217
PL - Polonia 1.251
SG - Singapore 1.074
DE - Germania 779
IT - Italia 720
CN - Cina 572
BR - Brasile 425
SE - Svezia 342
VN - Vietnam 261
FR - Francia 189
UA - Ucraina 182
GB - Regno Unito 163
IN - India 134
FI - Finlandia 103
IE - Irlanda 91
HK - Hong Kong 76
ID - Indonesia 76
CA - Canada 68
BD - Bangladesh 57
RU - Federazione Russa 47
JP - Giappone 43
MX - Messico 42
ES - Italia 39
AR - Argentina 36
TR - Turchia 36
IQ - Iraq 31
NL - Olanda 31
EC - Ecuador 24
BE - Belgio 23
SA - Arabia Saudita 19
CO - Colombia 16
AT - Austria 15
KR - Corea 15
ZA - Sudafrica 14
MA - Marocco 13
VE - Venezuela 12
CL - Cile 9
JM - Giamaica 9
UZ - Uzbekistan 8
JO - Giordania 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AU - Australia 6
CH - Svizzera 6
LT - Lituania 6
PE - Perù 6
PK - Pakistan 6
TH - Thailandia 6
BO - Bolivia 5
CR - Costa Rica 5
EG - Egitto 5
GR - Grecia 5
HN - Honduras 5
IL - Israele 5
IR - Iran 5
KE - Kenya 5
KZ - Kazakistan 5
PH - Filippine 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
HU - Ungheria 4
BB - Barbados 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
LB - Libano 3
LV - Lettonia 3
MY - Malesia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
LK - Sri Lanka 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
Totale 12.452
Città #
Warsaw 1.233
Ashburn 660
Singapore 586
San Jose 477
Chandler 441
Fairfield 245
Rome 156
Wilmington 142
Chicago 140
Houston 140
Jacksonville 140
Woodbridge 129
Council Bluffs 115
Beijing 109
Los Angeles 107
San Mateo 107
New York 102
Cattolica 98
Milan 97
Ho Chi Minh City 96
Seattle 96
Dublin 91
Verona 84
Ann Arbor 83
Cambridge 82
Buffalo 68
Hong Kong 68
Nanjing 63
Jakarta 61
Hefei 57
Helsinki 56
Lauterbourg 56
Munich 56
Dallas 50
Dearborn 49
Hanoi 49
Bremen 46
Salt Lake City 42
Redwood City 40
Santa Clara 40
Frankfurt am Main 37
São Paulo 37
Boston 36
Nürnberg 36
Tokyo 35
Lawrence 33
London 31
Nanchang 31
Phoenix 30
The Dalles 29
Moscow 28
Lancaster 24
Atlanta 23
Brooklyn 23
Boardman 21
Princeton 21
Toronto 21
Brussels 20
Nuremberg 20
Paris 19
Dong Ket 17
Elk Grove Village 16
Pune 16
Tampa 16
Belo Horizonte 15
Marseille 15
Mountain View 15
Chennai 14
Kraków 14
Manchester 14
Mexico City 14
Redmond 14
San Diego 14
Shanghai 14
Da Nang 13
Denver 13
Hangzhou 13
Kent 13
Rio de Janeiro 13
Seoul 13
University Park 13
Charlotte 12
Izmir 12
Norwalk 12
Shenyang 12
Amsterdam 11
Baghdad 11
Changsha 11
Guangzhou 11
Miami 11
North Bergen 11
Stockholm 11
Falkenstein 10
Fremont 10
Haiphong 10
Hyderabad 10
Jiaxing 10
Leawood 10
Montesilvano Marina 10
Montreal 10
Totale 7.616
Nome #
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 512
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 448
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 443
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 435
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 429
mTOR kinase: a possible pharmacological target in the management of chronic pain 418
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 391
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 374
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 364
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 298
Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapanisertib 269
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 232
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 228
Antiretrovirals inhibit arginase in human microglia 224
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 223
Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis 219
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 218
Variability of raltegravir plasma levels in the clinical setting 204
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis 198
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 198
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 192
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 184
Pro-inflammatory activation of a new immortalized human microglia cell line 180
Antiretrovirals inhibit arginase in human microglia 178
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 177
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 174
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 171
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 160
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 160
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 159
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 159
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 154
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 154
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 153
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 151
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 150
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents. The ONCOFID-P paradigm. 149
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 147
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 147
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 147
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 147
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 147
The effects of painless nerve growth factor on human microglia polarization 145
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 145
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 143
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy 138
The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment—A Systematic Review 134
A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19 134
Glioma-Associated Microglia Characterization in the Glioblastoma Microenvironment through A ‘Seed-and Soil’ Approach: A Systematic Review 133
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 132
Exploiting microglial functions for the treatment of glioblastoma 131
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 129
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 127
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 126
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 124
DNA inhibitors for the treatment of brain tumors 122
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 121
A topographic approach to the markers of macrophage/microglia and other cell types in high grade glioma 120
Interactions between Integrase Inhibitors and human Arginase 1 118
Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples 116
Exploiting Microglial Functions for the Treatment of Glioblastoma 115
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 113
The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids 97
Retinal Pigment Epithelium Cell Line ARPE-19 Exposed to M1 Microglia Releases Proinflammatory Cytokines and Reactive Oxygen Species Through MAP-Kinase Pathway 56
Mebendazole Shows Antiproliferative and Antimigratory Effects in Paediatric Low-Grade Glioma Models 28
Tumor growth inhibitory activity of the P2X7 receptor antagonist AZ10606120 in two cell lines of human glioblastoma 14
Erythropietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a non transcriptional mechanism 10
Totale 12.636
Categoria #
all - tutte 43.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022612 0 0 0 29 66 30 11 97 30 60 170 119
2022/20231.127 128 163 107 188 76 137 25 95 137 20 27 24
2023/2024607 35 146 27 53 27 68 65 33 9 13 52 79
2024/20251.584 23 34 102 53 88 58 24 61 189 120 596 236
2025/20263.742 471 129 261 400 551 176 657 162 273 260 164 238
2026/2027889 170 325 259 135 0 0 0 0 0 0 0 0
Totale 12.636